港股異動丨中富資源(0274.HK)復牌暴漲逾126% 終止配股
格隆匯4月23日丨中富資源(0274.HK)復牌暴漲逾126%,報0.217港元,高見0.25港元創去年7月以來新高,總市值2.74億港元。中富資源昨日公佈,於2021年3月1日,公司作為發行方與一名獨立第三方作為認購方訂立了認購協議。根據認購協議,公司擬向認購方有條件發行及配發公司新股份以籌集2.016億港元。監於認購方的財務狀況變動及長時間停牌情況,公司及認購方已同意終止認購協議。因此,公司與認購方於2021年4月22日訂立了終止協議。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.